Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Myriad Genetics Inc (MYGN)  
$23.95 4.17 (21.08%) as of 4:30 Wed 5/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,542,000
Market Cap: 2.26(B)
Last Volume: 2,587,962 Avg Vol: 691,753
52 Week Range: $13.91 - $23.73
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  618
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 30,000 38,638 109,679
Total Sell Value $0 $572,835 $771,595 $2,187,775
Total People Sold 0 1 2 3
Total Sell Transactions 0 1 2 9
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 1303
  Page 18 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2018-09-17 4 D $46.35 $301,970 D/D (6,515) 132,294     -
   Capone Mark Christopher President & C.E.O.   •       –      –    2018-09-17 4 D $46.35 $511,009 D/D (11,025) 321,150     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-09-17 4 D $46.35 $292,654 D/D (6,314) 110,260     -
   King Gary A. Exec. VP International Ops   •       –      –    2018-09-17 4 D $46.35 $236,431 D/D (5,101) 117,453     -
   Sanders Walter Lloyd President Myriad Oncology   •       –      –    2018-09-17 4 D $46.35 $39,119 D/D (844) 24,117     -
   Ford Alexander President, MGL   •       –      –    2018-09-17 4 D $46.35 $84,821 D/D (1,830) 75,660     -
   Mcdade Ralph L President Myriad RBM, Inc.   •       –      –    2018-09-17 4 D $46.35 $145,910 D/D (3,148) 105,530     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2018-07-11 4 AS $43.34 $2,167,040 D/D (50,000) 138,809     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2018-07-11 4 OE $30.34 $1,517,000 D/D 50,000 142,670     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-07-11 4 GD $0.00 $0 D/D 7,623 116,574     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-07-11 4 AS $42.02 $3,030,220 D/D (70,672) 124,197     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-07-11 4 OE $23.11 $1,633,230 D/D 70,672 164,197     -
   Henderson John T Director   –       •      –    2018-07-11 4 AS $40.17 $1,261,785 D/D (30,000) 49,743     -
   Henderson John T Director   –       •      –    2018-07-11 4 OE $24.39 $731,700 D/D 30,000 59,743     -
   Capone Mark Christopher President & C.E.O.   •       –      –    2018-07-11 4 AS $41.00 $3,280,000 D/D (80,000) 332,175     -
   Capone Mark Christopher President & C.E.O.   •       –      –    2018-07-11 4 OE $30.12 $2,409,600 D/D 80,000 334,521     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-06-18 4 AS $40.00 $1,320,000 D/D (33,000) 124,197     -
   Marsh Richard M E.V.P., General Counsel   •       –      –    2018-06-18 4 OE $30.34 $1,001,220 D/D 33,000 157,197     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2018-06-18 4 AS $40.12 $2,407,200 D/D (60,000) 138,809     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2018-06-18 4 OE $30.12 $1,807,200 D/D 60,000 141,155     -
   Langer Dennis Director   –       •      –    2018-06-08 4 S $39.35 $537,678 D/D (13,664) 39,743     -
   Langer Dennis Director   –       •      –    2018-06-08 4 OE $21.29 $290,907 D/D 13,664 53,407     -
   Langer Dennis Director   –       •      –    2018-06-07 4 S $39.35 $121,828 D/D (3,096) 39,743     -
   Langer Dennis Director   –       •      –    2018-06-07 4 OE $21.29 $65,914 D/D 3,096 42,839     -
   Langer Dennis Director   –       •      –    2018-06-06 4 S $39.37 $142,088 D/D (3,609) 39,743     -
  1303 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us